A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Pozen Inc.

About Pozen Inc.



POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience.

Pozen's initial focus is developing products for migraine therapy, a multi-billion dollar global market. POZEN has three product candidates, each designed with a unique profile to treat different stages of migraine attacks - mild, moderate and severe. Combined, these product candidates may offer patients and physicians the ability to customize migraine therapy.




TREXIMA --Migraine pain

Trexima is being developed as a novel combination of sumatriptan and naproxen sodium in a single tablet. The triptan alters the constriction of the blood vessels, which correlates to the relief of migraine pain. The NSAID inhibits the enzyme responsible for the production of prostaglandins, which are the mediators of pain and inflammation, thereby enhancing the speed, effectiveness and duration of migraine symptom relief.



Home Page

Key Statistics for Pozen

Basic Chart for Pozen

Analyst Opinion

Analysts Estimates

Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.